-
EP1863797
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1863797
| EP1863797 - 2-AZETIDINYL-4-(lH-PYRAZOL-3-YLAMINO)PYRIMIDINES AS INHIBITORS OF INSULIN-LIKE GROWTH FACTOR-I RECEPTOR ACTIVITY [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 29.05.2009 Database last updated on 19.10.2024 | Most recent event Tooltip | 29.05.2009 | Application deemed to be withdrawn | published on 01.07.2009 [2009/27] | Applicant(s) | For all designated states AstraZeneca AB 151 85 Södertälje / SE | [2007/50] | Inventor(s) | 01 /
THOMAS, Andrew Peter, AstraZeneca R & D Alderley Alderley Park Macclesfield, Cheshire SK10 4TG / GB | 02 /
NOWAK, Thorsten, AstraZeneca R & D Alderley Alderley Park Macclesfield, Cheshire SK10 4TG / GB | [2007/50] | Representative(s) | Bryant, Tracey AstraZeneca AB Global Intellectual Property 151 85 Sodertalje / SE | [N/P] |
| Former [2007/50] | Bryant, Tracey AstraZeneca AB, Global Intellectual Property 151 85 Sodertalje / SE | Application number, filing date | 06726448.1 | 21.03.2006 | [2007/50] | WO2006GB01013 | Priority number, date | GB20050005913 | 23.03.2005 Original published format: GB 0505913 | GB20050025952 | 21.12.2005 Original published format: GB 0525952 | [2007/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2006100461 | Date: | 28.09.2006 | Language: | EN | [2006/39] | Type: | A1 Application with search report | No.: | EP1863797 | Date: | 12.12.2007 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.09.2006 takes the place of the publication of the European patent application. | [2007/50] | Search report(s) | International search report - published on: | EP | 28.09.2006 | Classification | IPC: | C07D403/14, A61K31/506, A61P35/00 | [2007/50] | CPC: |
C07D417/14 (EP,US);
A61P35/00 (EP);
A61P43/00 (EP);
C07D413/14 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/50] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | YU | Not yet paid | Title | German: | 2-AZETIDINYL-4-(LH-PYRAZOL-3-YLAMINO)PYRIMIDINE ALS INHIBITOREN DER AKTIVITÄT DES REZEPTORS FÜR DEN INSULIN-LIKE GROWTH FACTOR-I | [2007/50] | English: | 2-AZETIDINYL-4-(lH-PYRAZOL-3-YLAMINO)PYRIMIDINES AS INHIBITORS OF INSULIN-LIKE GROWTH FACTOR-I RECEPTOR ACTIVITY | [2007/50] | French: | 2-AZETIDINYL-4-(LH-PYRAZOL-3-YLAMINO)PYRIMIDINES EN TANT QU'INHIBITEURS DE L'ACTIVITE DU RECEPTEUR DU FACTEUR DE CROISSANCE INSULINIQUE I | [2007/50] | Entry into regional phase | 23.10.2007 | National basic fee paid | 23.10.2007 | Designation fee(s) paid | 23.10.2007 | Examination fee paid | Examination procedure | 23.10.2007 | Examination requested [2007/50] | 28.08.2008 | Despatch of a communication from the examining division (Time limit: M04) | 08.01.2009 | Application deemed to be withdrawn, date of legal effect [2009/27] | 16.02.2009 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2009/27] | Fees paid | Renewal fee | 31.03.2008 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.03.2009 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO02068415 (VERTEX PHARMA [US], et al) [Y] 1-28 * abstract *; | [Y]WO0222607 (VERTEX PHARMA [US], et al) [Y] 1-28 * page 99; compounds IV-4 * * claim 1 *; | [Y]WO0245652 (MERCK & CO INC [US], et al) [Y] 1-28 * pages 144-145; compounds 53-8, 53-9, 53-13 * * page 142; compounds 53-2 *; | [DPY]WO2005040159 (ASTRAZENECA AB [SE], et al) [DPY] 1-28 * claim 1 *; | [PY]WO2005068468 (VERTEX PHARMA [US], et al) [PY] 1-28 * page 60; compounds I-7 * * page 61; compounds I-12 * |